Institutional Investors Increase AstraZeneca Holdings in Q3 2025
Multiple institutional investors expanded their positions in AstraZeneca during the third quarter of 2025, with several funds increasing holdings by over 100% according to SEC filings.
Fayez Sarofim & Co.
CompanyCompany Profile
Fayez Sarofim & Co. is an independent, employee-owned global investment manager focused on high-conviction sustainable growth investing. Founded in 1958, it is headquartered in Houston, Texas.
- Website
- https://sarofim.com
- Headquarters
- Houston, Texas, USA
- Founded
- 1958
Related News
Institutional Investors Increase AstraZeneca Holdings in Q3 2025
Multiple institutional investors expanded their positions in AstraZeneca during the third quarter, with AMG National Trust Bank, Cibc World Market Inc., and Advisors Asset Management Inc. increasing holdings by approximately 20%.